- Home
- PHAR vs PEBO Comparison
PHAR vs PEBO Comparison
Compare PHAR & PEBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- PEBO
- Stock Information
- Founded
- PHAR 1988
- PEBO 1902
- Country
- PHAR Netherlands
- PEBO United States
- Employees
- PHAR N/A
- PEBO N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- PEBO Major Banks
- Sector
- PHAR Health Care
- PEBO Finance
- Exchange
- PHAR Nasdaq
- PEBO Nasdaq
- Market Cap
- PHAR 951.7M
- PEBO 1.1B
- IPO Year
- PHAR N/A
- PEBO N/A
- Fundamental
- Price
- PHAR $13.86
- PEBO $31.11
- Analyst Decision
- PHAR Strong Buy
- PEBO Buy
- Analyst Count
- PHAR 3
- PEBO 7
- Target Price
- PHAR $30.00
- PEBO $36.14
- AVG Volume (30 Days)
- PHAR 13.2K
- PEBO 115.8K
- Earning Date
- PHAR 10-23-2025
- PEBO 10-21-2025
- Dividend Yield
- PHAR N/A
- PEBO 5.29%
- EPS Growth
- PHAR N/A
- PEBO N/A
- EPS
- PHAR N/A
- PEBO 2.93
- Revenue
- PHAR $339,836,000.00
- PEBO $554,422,000.00
- Revenue This Year
- PHAR $16.63
- PEBO N/A
- Revenue Next Year
- PHAR $6.77
- PEBO $3.45
- P/E Ratio
- PHAR N/A
- PEBO $10.59
- Revenue Growth
- PHAR 22.44
- PEBO 9.54
- 52 Week Low
- PHAR $7.31
- PEBO $26.21
- 52 Week High
- PHAR $17.08
- PEBO $37.07
- Technical
- Relative Strength Index (RSI)
- PHAR 51.52
- PEBO 58.31
- Support Level
- PHAR $13.63
- PEBO $29.61
- Resistance Level
- PHAR $15.27
- PEBO $30.77
- Average True Range (ATR)
- PHAR 0.98
- PEBO 0.60
- MACD
- PHAR -0.17
- PEBO -0.05
- Stochastic Oscillator
- PHAR 16.68
- PEBO 77.32
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About PEBO Peoples Bancorp Inc.
Peoples Bancorp Inc (Marietta OH) is a financial holding company. As a community bank, it offers a complete line of banking, insurance, investment, and trust solutions through its financial subsidiaries. It offers demand deposit accounts, savings accounts, real estate mortgage loans, merchant credit card transaction processing services, corporate and personal trust services, life, health, property, and casualty insurance products, and brokerage services. The bank also offers telephone and internet-based banking through both personal computers and mobile devices.